Home
Aperion Biologics Corporation

Aperion Biologics Corpor... Market Share Analysis for July 2026

Z-Lig, a better tissue alternative for ACL and knee surgery.

Industry: N/A

Domainaperionbiologics.com

Year Founded1996

Employees51 - 200

Annual Revenue$15M - $25M

Aperion Biologics Corporation

Aperion Biologics Corporation (including company regionals)

aperionbiologics.com

See more website traffic and engagement information

Aperion Biologics Corporation Revenue up to July 2026 is 15M - 25M

revenue generated by Aperion Biologics Corporation top domains

Aperion Biologics Corporation top domains revenue over 3 years

Revenue for Aperion Biologics Corporation top domains

aperionbiologics.com15M - 25M

See more with Sales Intelligence

Total visits to Aperion Biologics Corporation's top domains

Understand Aperion Biologics Corporation market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Aperion Biologics Corporation's top domains

Analyze Aperion Biologics Corporation engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Aperion Biologics Corporation's top domains

See how Aperion Biologics Corporation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Aperion Biologics Corporation top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Aperion Biologics Corporation

These are the website technologies, by industry, used by Aperion Biologics Corporation top domains

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Audio Video Media (1)

YouTube

Email Services (1)

GoDaddy Email

More Technologies

4

See all

News & Signals from Aperion Biologics Corporation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAperion Biologics Corporation hires Mike Ward.Aperion Biologics, Inc., a clinical-stage regenerative medical device company, announced that France Dixon Helfer and Mike Ward were appointed to the Company’s Board of Directors.